Artosyn, a Yangpu-based company that develops system-on-chip (SoCs) for drones, has raised a total corpus of over 500 million yuan ($78 million) in its Series B and B+ rounds of financing.
Four investors jointly led the round. These include three returning backers – Beijing IC Manufacturing and Equipment Equity Investment Fund, F&G Venture, and Huaxu (Guangzhou) Industry Investment Fund, besides new investor Chuanhu Innovation Fund, per an official company statement on Thursday.
Artosyn had raised its Series B round early last year wherein it had seen the participation of a host of investors.
Artosyn plans to use the corpus to rope in executives, and to facilitate product R&D, among others.
The company, established up in 2011 in Shanghai, develops high-performing chips that cater to areas of intelligent surveillance, smart car, and robots, besides drones.
CHINA DEAL MONITOR
DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region on January 05 – 06, 2022.
|Startup||Headquarter||Investment Size (USD)||Investment Stage||Lead Investor(s)||Other Investor(s)||Verticals|
|Virtue Diagnostics||Suzhou/Singapore/Beijing||100 million||B||Sequoia Capital, Morningside Ventures||Lilly Asia Ventures (LAV), PKI Ventures||HealthTech|
|Artosyn||Shanghai||78 million||B||Beijing IC Manufacturing and Equipment Equity Investment Fund, F&G Venture, Huaxu (Guangzhou) Industry Investment Fund, Chuanhu Innovation Fund||-||AI and Machine Learning|
|CureGenetics||Suzhou||60 million||B||Advantech Capital||BOCG Capital, Oriza Holdings, Qiming Venture Partners||Biotech|
|Accro Bioscience (Suzhou)||Suzhou||50 million||B||Hongtai Aplus||South China Venture Capital, Shenzhen Capital Group, Oriza Holdings, GF Xinde, Sanhua Hongdao||HealthTech|
|Atom Bioscience&Pharmaceutical||Suzhou||47 million||C||Xicheng Jinrui||-||HealthTech|
|Joyo||Guangzhou||31 million||B+||Guanzi Venture Capital||SDIC Venture Capital, Sequoia Capital China, LC Ventures||HealthTech|
|ZSHIELD INC||Beijing||* 15 million||C||Legend Capital||-||Big Data|
|X-EPIC||Nanjing||* 15 million||Pre-B+||China Development Manufacturing Transform Fund||-||AI and Machine Learning|
|SenWellen||Shenzhen||15 million||-||SME Development Fund (Nanjing)||Decent Capital, Xiangyu Jiahu, Yanfu Capital||N/A|
|Shengshi Science and Technology||Hangzhou||15 million||Pre-A||Bioventure Capital||Shanghai Bangming Capital, Institute of Innovation and Entreprenurship, Zhejiang University||HealthTech|
|Hongsong||Beijing||15 million||-||BAI Capital||Matrix Partners China, China Creation Venture (CCV), Bluerun Ventures||N/A|
|Redu Xingxuan||Hangzhou||15 million||A+||Plum Ventures||Zhiming Capital||Saas|
|Apifox||Guangzhou||5 million||Pre-A||Bluerun Ventures||China Growth Capital||Cloud Computing|
|CarbonEnergy Technology||Beijing||* 1.5 million||A||Sequoia Capital China||Miracleplus||CleanTech|
|OMG||Hangzhou||* 1.5 million||Angel||-||Plum Ventures||N/A|
|Little Rabbit||Shanghai||1.5 million||Angel||-||Cathay Capital, Kunyan Capital||HealthTech|
|Zhizu Huandian||Shanghai||-||B||QJMOTOR||Xuzhou Runhui||CleanTech|
∗ indicates that the company did not provide the specific size of the deal but only a range. So, we adopt the smallest number in the range, which is “10 million yuan ($1.5 million)” in the given example.